이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Dr. Reddy's Laboratories 관리
관리 기준 확인 2/4
Dr. Reddy's Laboratories' CEO는 Erez Israeli, Apr2018 에 임명되었습니다 의 임기는 6.17 년입니다. 는 ₹ 220.95M 가치에 해당하는 회사 주식의 0.022% 직접 소유합니다. 220.95M. 경영진과 이사회의 평균 재임 기간은 각각 6.2 년과 3.9 년입니다.
주요 정보
Erez Israeli
최고 경영자
₹197.1m
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 6.5yrs |
| CEO 소유권 | 0.007% |
| 경영진 평균 재임 기간 | 6.5yrs |
| 이사회 평균 재임 기간 | 2.8yrs |
최근 관리 업데이트
Recent updates
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?
Sep 28Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?
Aug 17CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹56b |
| Mar 31 2024 | ₹197m | n/a | ₹56b |
| Dec 31 2023 | n/a | n/a | ₹52b |
| Sep 30 2023 | n/a | n/a | ₹51b |
| Jun 30 2023 | n/a | n/a | ₹47b |
| Mar 31 2023 | ₹195m | n/a | ₹45b |
| Dec 31 2022 | n/a | n/a | ₹36b |
| Sep 30 2022 | n/a | n/a | ₹31b |
| Jun 30 2022 | n/a | n/a | ₹30b |
| Mar 31 2022 | ₹127m | n/a | ₹24b |
| Dec 31 2021 | n/a | n/a | ₹26b |
| Sep 30 2021 | n/a | n/a | ₹19b |
| Jun 30 2021 | n/a | n/a | ₹17b |
| Mar 31 2021 | ₹120m | n/a | ₹17b |
| Dec 31 2020 | n/a | n/a | ₹21b |
| Sep 30 2020 | n/a | n/a | ₹15b |
| Jun 30 2020 | n/a | n/a | ₹19b |
| Mar 31 2020 | ₹195m | ₹107m | ₹19b |
| Dec 31 2019 | n/a | n/a | ₹16b |
| Sep 30 2019 | n/a | n/a | ₹27b |
| Jun 30 2019 | n/a | n/a | ₹21b |
| Mar 31 2019 | ₹123m | n/a | ₹19b |
보상 대 시장: Erez 의 총 보상 ($USD 2.36M )은 Indian 시장( $USD 974.14K ).
보상과 수익: Erez 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Erez Israeli (56 yo)
6.5yrs
테뉴어
₹197,090,000
보상
Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Chairman | 38.5yrs | ₹186.28m | 13.08% ₹ 147.0b | |
| Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 153.0b | |
| CEO & Member of the Management Council | 6.5yrs | ₹197.09m | 0.0066% ₹ 73.6m | |
| CFO & Member of the Management Council | less than a year | ₹48.82m | 0.0057% ₹ 63.7m | |
| Global Head of Quality and Pharmacovigilance & Member of the Management Council | less than a year | ₹6.15m | 데이터 없음 | |
| CEO of API & Services & Member of Management Council | no data | ₹41.90m | 0.0027% ₹ 30.1m | |
| CEO of Branded Markets - India & Emerging Countries and Member of Management Council | no data | ₹82.74m | 0.016% ₹ 176.8m | |
| EVP, Head of Corporate Communications | 7.3yrs | ₹65.21m | 0.0063% ₹ 71.4m | |
| Executive VP | 7.2yrs | ₹66.05m | 데이터 없음 | |
| CEO of European Generics & Member of Management Council | no data | ₹63.09m | 데이터 없음 | |
| Global Head of Integrated Product Development Organisation & Member of the Management Council | no data | ₹55.63m | 0.000020% ₹ 224.8k | |
| Global Head – Biologics & Member of the Management Council | no data | ₹34.59m | 데이터 없음 |
6.5yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 관리: DRREDDY 의 관리팀은 노련하고 경험 (평균 재직 기간 6.2 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Chairman | 38.5yrs | ₹186.28m | 13.08% ₹ 147.0b | |
| Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 153.0b | |
| Member of the Scientific Advisory Board | no data | ₹8.36m | 데이터 없음 | |
| Independent Director | 2.2yrs | ₹18.77m | 데이터 없음 | |
| Independent Director | 5.8yrs | ₹13.34m | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Lead Independent Director | 6yrs | ₹17.10m | 데이터 없음 | |
| Independent Director | 2.8yrs | ₹14.18m | 데이터 없음 | |
| Independent Director | less than a year | ₹3.32m | 데이터 없음 | |
| Independent Director | 1.8yrs | ₹8.25m | 데이터 없음 | |
| Independent Director | 2.8yrs | ₹17.10m | 데이터 없음 | |
| Independent Director | 1.4yrs | ₹16.09m | 데이터 없음 |
2.8yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: DRREDDY 의 이사회는 경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.